Regenerative Medicine Challenges

Adeel highlights Japan's progressive stance on covering stem cell treatments for knee osteoarthritis, contrasting it with the political hurdles in the U.S. He emphasizes the difficulty in securing funding for regenerative medicine research, noting that even promising biotech companies struggle to find financial support for clinical trials. The conversation underscores the need for advocacy and lobbying to advance these innovative treatments in America.